HIKAL
Back to Cashflow Statement
|
HIKAL Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-3.40 Cr | ₹0.30 Cr | ₹-14 Cr | ₹15 Cr | ₹3.80 Cr |
What is the latest Net Cash Inflow / Outflow ratio of HIKAL ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-3.40 Cr |
| Mar2025 | ₹0.30 Cr |
| Mar2024 | ₹-14 Cr |
| Mar2023 | ₹15 Cr |
| Mar2022 | ₹3.80 Cr |
How is Net Cash Inflow / Outflow of HIKAL Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-3.40 Cr | Negative | |
| Mar2025 | ₹0.30 Cr | Positive | |
| Mar2024 | ₹-14 Cr | Negative | |
| Mar2023 | ₹15 Cr | 301.92 | |
| Mar2022 | ₹3.80 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,401.3 Cr | -9.6% | -14.5% | -15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -9.6% |
-14.5% |
-15.5% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses